Rocket Lab USA, Inc. — Q3 2023 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2023. Unless otherwise stated, financial amounts below are in U.S. dollars, millions.
Business context and results
Rocket Lab provides launch services and space systems, including spacecraft design, manufacturing, components and mission operations. It is developing Neutron, a medium-capacity launch vehicle, alongside its Electron launch business and Space Systems offerings.
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $67.7 | $63.1 | $184.6 | $159.2 |
| Gross profit (margin) | $15.0 (22.1%) | $8.5 (13.4%) | $35.9 (19.5%) | $17.2 (10.8%) |
| Operating loss | $(38.9) | $(32.0) | $(130.0) | $(98.0) |
| Net loss | $(40.6) | $(34.6) | $(132.1) | $(98.7) |
| Net loss per share, diluted | $(0.08) | $(0.07) | $(0.28) | $(0.21) |
Q3 revenue rose about 7%, primarily from Space Systems growth, partly offset by lower launch revenue per mission. Nine-month revenue increased about 16%, reflecting higher launch cadence and Space Systems growth. Q3 Space Systems revenue was $46.3 million; Launch Services revenue was $21.3 million. Nine-month segment revenue was $121.2 million for Space Systems and $63.4 million for Launch Services.
Cash, debt and liquidity
- At September 30, cash and cash equivalents were $140.9 million and marketable securities were $229.5 million, totaling $370.4 million, down from $481.0 million at December 31, 2022. Restricted cash was $3.6 million.
- Current assets were $506.2 million and current liabilities $303.8 million. The company reported $105.1 million outstanding on its Hercules secured term loan, classified as current and maturing June 1, 2024; no further availability remained under the facility. The loan is secured by substantially all company assets. The company said it was in compliance with covenants.
- For the first nine months, operating cash use was $56.7 million, investing cash use was $49.2 million and financing provided $4.9 million. Capital equipment and infrastructure purchases were $44.3 million; the Virgin Orbit asset acquisition involved $16.9 million of cash paid.
- Management said existing cash, cash equivalents and customer payments should cover working-capital and capital-expenditure needs for at least the next 12 months, while noting that future financing may be required depending on investment needs and business performance.
Material changes, outlook and risks
- Gross margin improved year over year, while operating and net losses widened as operating expenses rose. Nine-month R&D increased 63% to $81.6 million, mainly due to Neutron development, hiring and prototype spending; SG&A increased 30% to $84.4 million.
- Management reported backlog of $582.4 million at September 30, up from $503.6 million at year-end 2022. About 57% was expected to be recognized within 12 months. Backlog includes contracts that may have customer termination rights.
- Management anticipated building approximately 13 launch vehicles in 2023 and had completed nine launches through September 30. It expected Electron launches to resume as soon as late November after the September 19 second-stage power-system anomaly. The company reported FAA authorization to resume launches and described corrective measures, but said the investigation process was not yet complete; further delays could reduce near-term launch revenue. No specific financial guidance was provided.
- Launch Services cost and margin benefited during the first nine months from a $4.1 million release of a contract-loss provision and a $2.1 million employee retention credit. These non-recurring items should be considered when assessing underlying performance.
- Other unusual developments: Rocket Lab classified two helicopters held for sale after changing its Electron recovery strategy. One was sold on October 18 for $3.9 million before closing costs; its September carrying value was $2.7 million. A remaining helicopter was still held for sale at quarter-end.
- Management identified risks including launch failures and cadence limitations, Neutron development and execution, customer concentration and funding, government spending and regulation, supply-chain and cost pressures, foreign exchange, cybersecurity, and the need to fund continued investment. The filing also reports ineffective disclosure controls due to material weaknesses at SolAero involving segregation of duties and IT access/change controls; remediation was ongoing. Management nevertheless stated that the consolidated financial statements fairly presented the company’s financial position and results.
Important facts for investors to verify
- Electron’s return-to-flight timing, investigation closure and whether corrective measures prevent recurrence.
- Cash burn and investment requirements relative to the $370.4 million cash-and-marketable-securities balance, including repayment or refinancing of the $105.1 million term loan due in 2024.
- Whether backlog converts to revenue on schedule, including customer termination rights and customer funding capacity.
- Underlying margins excluding the identified non-recurring Launch Services benefits, and the trajectory of R&D and SG&A spending.
- Progress in remediating SolAero’s control weaknesses and maintaining effective reporting controls.